T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Launois, Pascal ^a,b   Drowart, Annie ^c,d   Bourreau, Eliane ^e   Couppie, Pierre ^f   Farber, Claire Micèhle ^c   Van Vooren, Jean Paul ^c   Huygen, Kris ^g  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c ERASME HOSPITAL   (Belgium)

^d BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^e INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

^f CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^g Scientific Service Immunology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; MYCOLYL TRANSFERASE ANTIGEN 85; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS;

ACYLTRANSFERASES; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, BACTERIAL; BELGIUM; FRENCH GUIANA; HIV; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 78349256679     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/640309     Document Type: Article

References (41)

1. WHO, Vaccine preventable diseasesglobal summary. 2001
2. Tiruviluamala P., Reichman L. B., Tuberculosis Annual Review of Public Health 2002 23 403 426
3. Corbett E. L., Watt C. J., Walker N., Maher D., Williams B. G., Raviglione M. C., Dye C., The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Archives of Internal Medicine 2003 163 9 1009 1021
4. Corbett E. L., HIV and tuberculosis: surveillance revisited International Journal of Tuberculosis and Lung Disease 2003 7 8 709
5. Orme I. M., Preclinical testing of new vaccines for tuberculosis: a comprehensive review Vaccine 2006 24 1 2 19
6. Kaufmann S. H. E., Envisioning future strategies for vaccination against tuberculosis Nature Reviews Immunology 2006 6 9 699 704
7. van Dissel J. T., Arend S. M., Prins C., Bang P., Tingskov P. N., Lingnau K., Nouta J., Klein M. R., Rosenkrands I., Ottenhoff T. H.M., Kromann I., Doherty T. M., Andersen P., Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in nave human volunteers Vaccine 2010 28 20 3571 3581
8. McShane H., Pathan A. A., Sander C. R., Keating S. M., Gilbert S. C., Huygen K., Fletcher H. A., Hill A. V. S., Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans Nature Medicine 2004 10 11 1240 1244
9. Von Eschen K., Morrison R., Braun M., Ofori-Anyinam O., De Kock E., Pavithran P., Koutsoukas M., Moris P., Cain D., Dubois M.-C., Cohen J., Ballou W. R., The candidate tuberculosis vaccine Mtb72F/AS02A: tolerability and immunogenicity in humans Human Vaccines 2009 5 7 475 482
10. Andersen P., Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins Infection and Immunity 1994 62 6 2536 2544
11. Pal P. G., Horwitz M. A., Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis Infection and Immunity 1992 60 11 4781 4792
12. Wiker H. G., Harboe M., The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis Microbiological Reviews 1992 56 4 648 661
13. Running D. R., Klabunde T., Besra G. S., Vissa V. D., Belisle J. I., Sacchettini J. C., Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines Nature Structural Biology 2000 7 2 141 146
14. Armitige L. Y., Jagannath C., Wanger A. R., Norris S. J., Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages Infection and Immunity 2000 68 2 767 778
15. Huygen K., Content J., Denis O., Montgomery D. L., Yawman A. M., Deck R. R., Dewitt C. M., Orme I. M., Baldwin S., D'Souza C., Drowart A., Lozes E., Vandenbussche P., Van Vooren J.-P., Liu M. A., Ulmer J. B., Immunogenicity and protective efficacy of a tuberculosis DNA vaccine Nature Medicine 1996 2 8 893 898
16. Kamath A. T., Feng C. G., Macdonald M., Briscoe H., Britton W. J., Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis Infection and Immunity 1999 67 4 1702 1707
17. Baldwin S. L., D'Souza C. D., Orme I. M., Liu M. A., Huygen K., Denis O., Tang A., Zhu L., Montgomery D., Ulmer J. B., Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A Tubercle and Lung Disease 1999 79 4 251 259 (Pubitemid 29446013)
18. Andersen P., Gicquel B., Huygen K., Rom W. N., Garay S. M., Tuberculosis vaccine science Tuberculosis 2004 2nd Philadelphia, Pa, USA Lippincott Williams Wilkins 885 898
19. Langermans J. A. M., Doherty T. M., Vervenne R. A. W., Van Der Laan T., Lyashchenko K., Greenwald R., Agger E. M., Aagaard C., Weiler H., Van Soolingen D., Dalemans W., Thomas A. W., Andersen P., Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6 Vaccine 2005 23 21 2740 2750
20. Launois P., DeLeys R., Niang M. N., Drowart A., Andrien M., Dierckx P., Cartel J.-L., Sarthou J.-L., Van Vooren J.-P., Huygen K., T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy Infection and Immunity 1994 62 9 3679 3687
21. Launois P., Niang M. N., De Bruyn J., Sarthou J.-L., Rivier F., Drowart A., Van Vooren J.-P., Millan J., Huygen K., The major secreted antigen complex (Ag 85) from Mycobacterium bovis bacille Calmette-Guerin is associated with protective T cells in leprosy: a follow-up study of 45 household contacts Journal of Infectious Diseases 1993 167 5 1160 1167
22. Huygen K., Abramowicz D., Vandenbussche P., Jacobs F., De Bruyn J., Kentos A., Drowart A., Van Vooren J.-P., Goldman M., Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice Infection and Immunity 1992 60 7 2880 2886
23. Huygen K., Van Vooren J.-P., Turneer M., Bosmans R., Dierckx P., De Bruyn J., Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis Scandinavian Journal of Immunology 1988 27 2 187 194
24. Launois P., Huygen K., De Bruyn J., N'Diaye M., Diouf B., Sarthouj L., Grimaud J., Millan J., T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Gurin (BCG) in leprosy patients Clinical and Experimental Immunology 1991 86 2 286 290
25. Whelan K. T., Pathan A. A., Sander C. R., Fletcher H. A., Poulton I., Alder N. C., Hill A. V. S., McShane H., Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A PLoS ONE 2009 4 6
26. Doherty T. M., Olsen A. W., Weischenfeldf J., Huygen K., D'Souza S., Kondratieva T. K., Yeremeev V. V., Apt A. S., Raupach B., Grode L., Kaufmann S., Andersen P., Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis Journal of Infectious Diseases 2004 190 12 2146 2153
27. De Bruyn J., Huygen K., Bosmans R., Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG Microbial Pathogenesis 1987 2 5 351 366 (Pubitemid 17089538)
28. Dye C., Scheels S., Dolin P., Pathania M. B. A., Raviglione M. C., Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring project Journal of the American Medical Association 1999 282 677 686
29. Quigley M. A., Mwinga A., Hosp M., Lisse I., Fuchs D., Porter J. D. H., Godfrey-Faussett P., Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected zambian adults AIDS 2001 15 2 215 222
30. Lim H. J., Okwera A., Mayanja-Kizza H., Ellner J. J., Mugerwa R. D., Whalen C. C., Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults HIV Clinical Trials 2006 7 4 172 183
31. Johnson J. L., Okwera A., Hom D. L., Mayanja H., Kityo C. M., Nsubuga P., Nakibali J. G., Loughlin A. M., Yun H., Mugyenyi P. N., Vernon A., Mugerwa R. D., Ellner J. J., Whalen C. C., Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults AIDS 2001 15 16 2137 2147
32. CDC, Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR Recommendations and Reports: Morbidity and Mortality Weekly Report 1992 41 17 1 19
33. Collazos J., Knobel H., Casado J. L., CD4 count and viral load time-courses in patients treated with highly active antiretroviral therapy and association with the CDC staging system HIV Medicine 2006 7 8 504 513
34. Autran B., Effects of antiretroviral therapy on immune reconstitution Antiviral Therapy 1999 4 3 3 6 (Pubitemid 29512108)
35. Autran B., Carcelain G., Li T. S., Blanc C., Mathez D., Tubiana R., Katlama C., Debr P., Leibowitch J., Positive effects of combined antiretroviral therapy on CD 4+ T cell homeostasis and function in advanced HIV disease Science 1997 277 5322 112 116
36. D'Souza S., Romano M., Korf J., Wang X.-M., Adnet P.-Y., Huygen K., Partial reconstitution of the CD 4+ -T-cell compartment in CD4 gene knockout mice restores responses to tuberculosis DNA vaccines Infection and Immunity 2006 74 5 2751 2759
37. Silveira H., Ordway D., Dockrell H., Jackson M., Ventura F., Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection Clinical and Experimental Immunology 1997 110 1 26 34
38. Chapman A. L. N., Munkanta M., Wilkinson K. A., Pathan A. A., Ewer K., Ayles H., Reece W. H., Mwinga A., Godfrey-Faussett P., Lalvani A., Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis -specific T cells AIDS 2002 16 17 2285 2293
39. Vuola J. M., Ristola M. A., Cole B., Jrviluoma A., Tvaroha S., Rnkk T., Rautio O., Arbeit R. D., Von Reyn C. F., Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial AIDS 2003 17 16 2351 2355
40. Lahey T., Matee M., Mtei L., Bakari M., Pallangyo K., von Reyn C. F., Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis BMC Infectious Diseases 2009 9, article 21
41. Matee M., Lahey T., Vuola J. M., Mtei L., Cole B. F., Bakari M., Arbeit R. D., Horsburgh C. R., Pallangyo K., Von Reyn C. F., Baseline mycobacterial immune responses in HIV-infected adults primed with bacille Calmette-Gurin during childhood and entering a tuberculosis booster vaccine trial Journal of Infectious Diseases 2007 195 1 118 123